Once-weekly albiglutide in the management of type 2 diabetes: patient considerations

This review describes the pharmacologic, pharmacokinetic, and pharmacodynamic properties of albiglutide, as well as its clinical efficacy and safety. Albiglutide is a novel, once-weekly, injectable glucagon-like peptide-1 receptor agonist for the treatment of type 2 diabetes. The European Commission...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodward, Heather N, Anderson, Sarah L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049886/
https://www.ncbi.nlm.nih.gov/pubmed/24926194
http://dx.doi.org/10.2147/PPA.S53075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049886/
https://www.ncbi.nlm.nih.gov/pubmed/24926194
http://dx.doi.org/10.2147/PPA.S53075

Ejemplares similares